Diligence memo · auto-generated · as of July 2, 2026
Zealth, Inc.
Zealth, Inc. looks over-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Zealth, Inc. operates in Healthtech, based in SAN MATEO, KA, India; Remote. Software for remote monitoring of cancer patients
Sub-sector tags: Health Tech, Oncology, Remote, healthtech.
Capital & rounds (filed)filed
Zealth, Inc. has raised $95M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Series C (a $40M–$100M round).
Largest single filing: $95M on 2021-10-27.
Most recent recorded round closed around 2021-10-27.
Valuation (modeled)modeled
Provath models Zealth, Inc. at approximately $1.7B (range $345M–$3.7B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Over-valued. Modeled value is 1.55× the median modeled value of Series C Healthtech companies in 2019–2021 (33 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Last raise 4.7 yr ago; this sector typically re-raises about every 14 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 96% of Healthtech peers (2138 compared).
Modeled value ranks above 99% of those peers.
Closest niche peers: Virta Health Corp., Fresenius Medical Care Voorhees, LLC, Clear Health Pass Holdings LLC, Jawbone Health Hub, Inc., Boston Health Economic Holdings, LLC.
Peoplefiled
4 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
Modeled above niche peers — valuation risk on entry.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.